Smith & Nephew boosts 2025 cashflow forecast and unveils medium-term targets

Core Insights - British medical products maker Smith & Nephew raised its 2025 free cash flow forecast to around $800 million [1] - The company unveiled new medium-term targets ahead of its Capital Markets Day Event [1] Company Summary - Smith & Nephew is focusing on enhancing its financial outlook by increasing its free cash flow forecast [1] - The announcement of new medium-term targets indicates a strategic shift or growth plan for the company [1] Industry Context - The medical products industry is witnessing companies setting ambitious financial targets to drive growth and investor confidence [1]